Arkolith/Insider Trading/LEXX/Form 4

Bunka Christopher

DirectorLexaria Bioscience Corp. (LEXX) · full profile →Form 4 · filed Jul 30, 2025
Net Buying
Open-Market Buys
$25K
Open-Market Sells
$0
Net Open-Market Flow
$25K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 30, 2025Buy(P)12K$0.91$11K282K
Jul 29, 2025Buy(P)16K$0.92$14K270K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001348362-25-000016) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML